跳至主要内容
临床试验/NCT03671161
NCT03671161已完成不适用

Combination of Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes and Poor Glycemic Control Related to Very Few Self-blood Glucose Measurements

Groupe Hospitalier Pitie-Salpetriere1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
19
试验地点
1
主要终点
Change in HbA1c ≥1%

研究概览

简要总结

Patients with diabetes type 1 with poor glycemic control will be switched to insulin pump and FGM system (Flash Glucose Monitoring) during 6 months, correlated to the hypothesis that they could benefit from this intervention by being reengaged in diabetes self-management.

详细描述

This is a non-controlled proof of concept prospective pilot study in adults with type 1 diabetes, HbA1c >9% (75 mmol/mol), multi daily insulin injections ( MDI) and who perform less than 2 SMBG /day. Patients will be switched to insulin pump and started a FGM system (Free Style Libre®) during 6 months, hoping this intervention can reengage patients in self-management, reduce HbA1c without increasing the risk of ketoacidocetosis (DKA) and severe hypoglycemia (SH), and keep the DTSQ (Diabetes Treatment Satisfaction Questionnaire) and HFS (Hypoglycemia Fear Scale) at good levels.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •adults with type 1 diabetes, aged between 18 and 55, HbA1c >9% (75 mmol/mol), multi daily insulin injections (MDI) treatment, maximum 2 SMBG /day

排除标准

  • •diabetes with less than 1 year duration, severe active retinopathy requiring laser therapy, severe psychiatric illness, pregnancy, inability to communicate in French, concomitant severe active disease, patients already using a FGM or a CGM

研究组 & 干预措施

Patients with poorly controlled diabetes type 1

Experimental

Adults with type 1 diabetes, HbA1c >9% (75 mmol/mol), multi daily insulin injections ( MDI) and who perform less than 2 SMBG /day swithced to Insulin Pump and flash glucose monitoring

干预措施: Insulin Pump and flash glucose monitoring (Device)

结局指标

主要结局

Change in HbA1c ≥1%

时间窗: 6 months

Blood samples at baseline and 6 months

Number of ketoacidosis episodes

时间窗: 6 months

Number of severe hypoglycemia episodes

时间窗: 6 months

Number of severe hypoglycemia episodes, evaluated by flash glucose monitoring

次要结局

  • Frequency of severe hypoglycemia episodes(6 months)
  • Frequency of ketoacidosis episodes(6 months)
  • Any changes in Weight(6 months)
  • Any positive change in DTSQ scale (ΔDTSQM6-DTSQM0>0) (Diabetes Treatment Satisfaction Questionnaire)(6 months)
  • Number of Hypoglycemia episodes(6 months)
  • Any positive change in HFS scale (Hypoglycemia Fear Scale)(6 months)
  • Frequency of hypoglycemia episodes(6 months)

研究者

发起方
Groupe Hospitalier Pitie-Salpetriere
申办方类型
Other
责任方
Principal Investigator
主要研究者

Joe Elie Salem

Assistant director, clinical investigation center Paris Est

Groupe Hospitalier Pitie-Salpetriere

研究点 (1)

Loading locations...

相似试验